Measuring TSH receptor antibody to influence treatment choices in Graves' disease.

about

Graves Disease in Central Ghana: Clinical Characteristics and Associated Factors.Graves' hyperthyroidism in pregnancy: a clinical review.

P2860

Q52624750-5EEBE675-2C31-4AC1-9D7E-407AC0A2393D Q55323533-C0FE8D3D-59ED-4C81-A07E-4B7E524EEC30

P2860

Measuring TSH receptor antibody to influence treatment choices in Graves' disease.

Item

http://www.wikidata.org/entity/Q48125225

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Measuring TSH receptor antibody to influence treatment choices in Graves' disease.

@en

Measuring TSH receptor antibody to influence treatment choices in Graves' disease.

@nl

type

Item

label

Measuring TSH receptor antibody to influence treatment choices in Graves' disease.

@en

Measuring TSH receptor antibody to influence treatment choices in Graves' disease.

@nl

prefLabel

Measuring TSH receptor antibody to influence treatment choices in Graves' disease.

@en

Measuring TSH receptor antibody to influence treatment choices in Graves' disease.

@nl

P1476

Measuring TSH receptor antibody to influence treatment choices in Graves' disease

@en

P2093

Prakash Abraham

http://www.w3.org/2001/XMLSchema#string

P2860

Antithyroid drug regimen for treating Graves' hyperthyroidism

TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study

2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum.

A stimulatory TSH receptor antibody enhances adipogenesis via phosphoinositide 3-kinase activation in orbital preadipocytes from patients with Graves' ophthalmopathy.

Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.

Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor.

The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

Clinical review: Clinical utility of TSH receptor antibodies.

Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay

Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.

P304

652-657

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CEN.13327

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Asha Hesarghatta Shyamasunder

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28295509

http://www.w3.org/2001/XMLSchema#string

Measuring TSH receptor antibody to influence treatment choices in Graves' disease.

about

P2860

P2860

Measuring TSH receptor antibody to influence treatment choices in Graves' disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698